The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 1023-1029

  Ding, Mingxing ^a   Fu, Xiaoyan ^a   Tan, Haidong ^b   Wang, Ruiquan ^b   Chen, Zhimei ^b   Ding, Shiping ^c  

^a Jinhua College of Profession and Technology   (China)

^b Jinhua People's Hospital   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Lymphangiogenesis; r associated mBreast cancer; Tumoacrophages; Vascular endothelial growth factor C

Indexed keywords

CHLORDANE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPH VESSEL INVASION; LYMPHANGIOGENESIS; LYMPHATIC ENDOTHELIAL CELL PROLIFERATION; LYMPHATIC MICROVESSEL DENSITY; MALE; MICROSCOPY; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MACROPHAGES; MIDDLE AGED; NEOPLASM STAGING; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84866451790     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1043     Document Type: Article

References (29)

1. Sleeman JP and Thiele W: Tumor metastasis and the lymphatic vasculature. Int J Cancer 125: 2747-2756, 2009.
2. Achen MG and Stacker SA: Molecular control of lymphatic metastasis. Ann N Y Acad Sci 1131: 225-234, 2008. (Pubitemid 351758517)
3. Schoppmann SF, Birner P, Stockl J, et al: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947-956, 2002. (Pubitemid 34988382)
4. Zhang B, Wang J, Gao J, et al: Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem 107: 134-143, 2009.
5. Moussai D, Mitsui H, Pettersen JS, et al: The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J Invest Dermatol 131: 229-236, 2011.
6. Sundar SS and Ganesan TS: Role of lymphangiogenesis in cancer. J Clin Oncol 25: 4298-4307, 2007. (Pubitemid 47548571)
7. Kerjaschki D: The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115: 2316-2319, 2005.
8. Schoppmann SF, Fenzl A, Nagy K, et al: VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139: 839-846, 2006. (Pubitemid 43902914)
9. Van der Auwera I, Van den Eynden GG, Colpaert CG, et al: Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 11: 7637-7642, 2005. (Pubitemid 41611604)
10. Omachi T, Kawai Y, Mizuno R, et al: Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett 246: 167-172, 2007. (Pubitemid 44959388)
11. Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA and Marks AN: Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 20: 183-191, 2007. (Pubitemid 46422172)
12. Solinas G, Germano G, Mantovani A and Allavena P: Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86: 1065-1073, 2009.
13. Knowles HJ and Harris AL: Macrophages and the hypoxic tumour microenvironment. Front Biosci 12: 4298-4314, 2007.
14. Massi D, Puig S, Franchi A, et al: Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 59: 166-173, 2006. (Pubitemid 43235582)
15. Fernandez MI, Bolenz C, Trojan L, et al: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol 53: 571-578, 2008.
16. Trojan L, Rensch F, Voss M, et al: The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int 98: 903-906, 2006. (Pubitemid 44368047)
17. Aishima S, Nishihara Y, Iguchi T, et al: Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 21: 256-264, 2008. (Pubitemid 351304278)
18. Schoppmann SF, Bayer G, Aumayr K, et al: Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240: 306-312, 2004. (Pubitemid 38963023)
19. Van den Eynden GG, Van der Auwera I, Van Laere SJ, et al: Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J Pathol 213: 56-64, 2007. (Pubitemid 47354566)
20. Krishnan J, Kirkin V, Steffen A, et al: Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63: 713-722, 2003. (Pubitemid 36158152)
21. Wissmann C and Detmar M: Pathways targeting tumor lymphangiogenesis. Clin Cancer Res 12: 6865-6868, 2006. (Pubitemid 44974477)
22. Su JL, Yen CJ, Chen PS, et al: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96: 541-545, 2007.
23. Sica A, Schioppa T, Mantovani A and Allavena P: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727, 2006.
24. Royston D and Jackson DG: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 217: 608-619, 2009.
25. He Y, Karpanen T and Alitalo K: Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654: 3-12, 2004. (Pubitemid 38230927)
26. He Y, Rajantie I, Pajusola K, et al: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65: 4739-4746, 2005. (Pubitemid 40740810)
27. Zhang XH, Huang DP, Guo GL, et al: Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 8: 4, 2008.
28. Wang XL, Fang JP, Tang RY and Chen XM: Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer 10: 299, 2010.
29. Botting SK, Fouad H, Elwell K, et al: Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Transl Oncol 3: 170-175, 2010.